MALIGNANT NEOPLASM PROGRESSION side effect
What is MALIGNANT NEOPLASM PROGRESSION ?Drugs associated with MALIGNANT NEOPLASM PROGRESSION
ABELCET ABRAXANE ACTIQ ALIMTA AMNESTEEM ARANESP ARIMIDEX ARIXTRA AVONEX BARACLUDE BEVACIZUMAB BLEOMYCIN BRIPLATIN BUSPAR CAMPATH CAPECITABINE CARBOPLATIN CETUXIMAB CISPLATIN CLOZARIL CYCLOPHOSPHAMIDE CYCLOSPORINE CYTOTOXIC DACARBAZINE DASATINIB DECADRON DECITABINE DEPOCYT DEXAMETHASONE DILAUDID DOCETAXEL DOXORUBICIN DURAGESIC EFAVIRENZ ELOXATIN ENDOXAN ERBITUX ERLOTINIB ETOPOSIDE FEMARA FLONASE FLUDARA FLUOROURACIL FOLINIC FORTEO FOSAMAX GEMCITABINE GEMZAR GLEEVEC HOLOXAN HYDREA HYDROXYCARBAMIDE IFOSFAMIDE IMATINIB INTRON IRESSA ISOTRETINOIN IXEMPRA LAMIVUDINE LEUPROLIDE LEXAPRO LUCRIN LYRICA LYSODREN MEGACE METHOTREXATE METHYLPREDNISOLO MITOMYCIN NEULASTA NEUPOGEN NEXAVAR NILOTINIB OXYCODONE OXYCONTIN PACLITAXEL PALLADONE PANITUMUMAB PARAPLATIN PEMETREXED PHOTOFRIN PRIALT PROCRIT PROGRAF PROPRANOLOL REBIF RENAGEL REVLIMID SANDOSTATIN SORAFENIB SPRYCEL SUNITINIB SUTENT SYNTHROID TARCEVA TAXOL TEMODAL TEMODAR TEMOZOLOMIDE THALIDOMIDE THALOMID VALCYTE VELCADE VEPESID VESICARE VIDAZA VINCRISTINE VINORELBINE XALATAN XIGRIS ZEVALIN ZOFRAN ZOMETAMALIGNANT NEOPLASM PROGRESSION : Carboplatin Side Effects Report #5646462-3
Health Professional from GERMANY reported CARBOPLATIN problem on Feb 29, 2008. Male patient, 45 years of age, was diagnosed with non-small cell lung cancer, prophylaxis, constipation, infection, insomnia, cough and was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, pulmonary haemorrhage, . CARBOPLATIN dosage: TAKEN 934 MG IV ON 08FEB07-08FEB07 (1 DAY), 28-FEB07-28FEB07 (1 DAY) AND 21MAR07-21MAR07 (1 DAY).. During the same period patient was treated with PACLITAXEL, SORAFENIB, ASPIRIN, SENOKOT, CLEOCIN HYDROCHLORIDE, AMBIEN, ROBITUSSIN. Patient died on 04/06/2007.
MALIGNANT NEOPLASM PROGRESSION : Carboplatin Side Effects Report #5650367-1
CARBOPLATIN problem was reported by a Health Professional from GERMANY on Mar 03, 2008. Female patient, 75 years of age, was diagnosed with non-small cell lung cancer and was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, . CARBOPLATIN dosage: unknown. During the same period patient was treated with PACLITAXEL, SORAFENIB, SYNTHROID, ESTRADIOL, NIFEDIPINE, HYDROCHLOROTHIAZIDE, ZOLOFT. Patient died on 07/04/2006.
MALIGNANT NEOPLASM PROGRESSION : Baraclude Side Effects Report #5651087-X
Consumer or non-health professional from SINGAPORE reported BARACLUDE problem on Feb 28, 2008. Male patient, 57 years of age, was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, prostate cancer, renal disorder, . BARACLUDE dosage: unknown. During the same period patient was treated with LAMIVUDINE. Patient died.
MALIGNANT NEOPLASM PROGRESSION : Revlimid Side Effects Report #5651679-8
REVLIMID problem was reported by a Physician from UNITED STATES on Feb 27, 2008. Male patient, 67 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, multiple myeloma, . REVLIMID dosage: 25 MG, 1 IN 1 D, ORAL. Patient died on 12/30/2007.
MALIGNANT NEOPLASM PROGRESSION : Revlimid Side Effects Report #5654261-1
Physician from UNITED STATES reported REVLIMID problem on Feb 26, 2008. Female patient, 71 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, metastases to kidney, multiple myeloma, . REVLIMID dosage: 15 MG, X 21 DAYS, ORAL. Patient recovered.
MALIGNANT NEOPLASM PROGRESSION : Velcade Side Effects Report #5656259-6
VELCADE problem was reported by a Physician from UNITED KINGDOM on Feb 21, 2008. Female patient, 75 years of age, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, multiple myeloma, . VELCADE dosage: 2.40 MG; 1.30 MG. Patient died on 01/31/2008.
MALIGNANT NEOPLASM PROGRESSION : Revlimid Side Effects Report #5657999-5
Physician from UNITED STATES reported REVLIMID problem on Feb 29, 2008. Male patient, 83 years of age, was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, myelodysplastic syndrome, . REVLIMID dosage: 10 MG, 1 IN 1 D, ORAL. Patient died on 12/05/2007.
MALIGNANT NEOPLASM PROGRESSION : Ifosfamide Side Effects Report #5660851-2
IFOSFAMIDE problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 03, 2008. Male patient, 64 years of age, was diagnosed with diffuse large b-cell lymphoma, prophylaxis and was treated with IFOSFAMIDE. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, ototoxicity, pneumonia streptococcal, pulmonary cavitation, . IFOSFAMIDE dosage: unknown. During the same period patient was treated with MESNA, ETOPOSIDE, CARBOPLATIN, MABTHERA, LOSEC I, SIMVASTATIN, ASPIRIN. Patient was hospitalized. Patient died on 04/04/2005.
MALIGNANT NEOPLASM PROGRESSION : Zofran Side Effects Report #5661700-9
Consumer or non-health professional from UNITED STATES reported ZOFRAN problem on Mar 05, 2008. Male patient, 36 years of age, was treated with ZOFRAN. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, . ZOFRAN dosage: unknown. Patient was hospitalized. Patient died on 02/22/2008.
MALIGNANT NEOPLASM PROGRESSION : Docetaxel Side Effects Report #5669756-4
DOCETAXEL problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 13, 2008. Male patient, weighting 156.5 lb, was diagnosed with oesophageal cancer metastatic and was treated with DOCETAXEL. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, oesophageal cancer metastatic, pneumonia, staphylococcal infection, . DOCETAXEL dosage: 30MG/M2 IV BOLUS. During the same period patient was treated with BEVACIZUMAB D, IRINOTECAN, CISPLATIN. Patient was hospitalized. Patient recovered.
MALIGNANT NEOPLASM PROGRESSION : Revlimid Side Effects Report #5671705-X
Physician from UNITED STATES reported REVLIMID problem on Mar 10, 2008. Male patient, 42 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, multiple myeloma, nasopharyngitis, pancytopenia, pelvic pain, tremor, . REVLIMID dosage: 25 MG, QD FOR THREE WEEKS, ORAL. During the same period patient was treated with DEXAMETHASONE, KADIAN, MS CONTIN, HEPARIN. Patient died on 08/25/2007.
MALIGNANT NEOPLASM PROGRESSION : Revlimid Side Effects Report #5675869-3
REVLIMID problem was reported by a Physician from UNITED STATES on Mar 12, 2008. Male patient, 80 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, multiple myeloma, . REVLIMID dosage: 25 MG, 1 IN 1 D, ORAL. Patient died on 01/26/2008.
MALIGNANT NEOPLASM PROGRESSION : Cisplatin Side Effects Report #5676990-6
Consumer or non-health professional from IRELAND reported CISPLATIN problem on Mar 20, 2008. Male patient, 63 years of age, was diagnosed with gastric cancer, nausea, diabetes mellitus, hypertension, blood cholesterol and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, neutropenic sepsis, renal failure, . CISPLATIN dosage: unknown. During the same period patient was treated with FLUOROURACIL, METOCLOPRAMIDE, METFORMIN, GLIMEPIRIDE, DOXAZOSIN, ATORVASTATIN CALCIUM, VALSARTAN, ATENOLOL. Patient was hospitalized. Patient died on 06/08/2006.
MALIGNANT NEOPLASM PROGRESSION : Revlimid Side Effects Report #5678331-7
REVLIMID problem was reported by a Physician from UNITED STATES on Mar 17, 2008. Male patient, 80 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, non-hodgkin's lymphoma, rash, red blood cell count decreased, . REVLIMID dosage: 10 MG - 25 MG, QD, ORAL; 20 MG, X21 DAYS EVERY 28 DAYS, ORAL. Patient died on 02/07/2008.
MALIGNANT NEOPLASM PROGRESSION : Revlimid Side Effects Report #5678332-9
Physician from UNITED STATES reported REVLIMID problem on Mar 17, 2008. Male patient, 75 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, multiple myeloma, . REVLIMID dosage: 25 MG, 1 IN 1 D, ORAL; 10 MG, 1 IN 1 D, ORAL. Patient died.
MALIGNANT NEOPLASM PROGRESSION : Revlimid Side Effects Report #5678334-2
REVLIMID problem was reported by a Physician from UNITED STATES on Mar 17, 2008. Female patient, 73 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, multiple myeloma, . REVLIMID dosage: 15 MG, 1 IN 1 D, ORAL. Patient died on 01/04/2008.
MALIGNANT NEOPLASM PROGRESSION : Revlimid Side Effects Report #5678337-8
Physician from UNITED STATES reported REVLIMID problem on Mar 17, 2008. Female patient, 59 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, multiple myeloma, . REVLIMID dosage: 25 MG, 1 IN 1 D, ORAL. Patient died on 02/01/2008.
MALIGNANT NEOPLASM PROGRESSION : Avonex Side Effects Report #5679640-8
AVONEX problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 11, 2008. Female patient, 32 years of age, was diagnosed with multiple sclerosis and was treated with AVONEX. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, uterine cancer, . AVONEX dosage: unknown. Patient was hospitalized. Patient recovered.
MALIGNANT NEOPLASM PROGRESSION : Revlimid Side Effects Report #5679670-6
Physician from UNITED STATES reported REVLIMID problem on Mar 17, 2008. Male patient, 61 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, multiple myeloma, . REVLIMID dosage: 25 MG, 1 IN 1 D, ORAL. Patient died on 01/01/2007.
MALIGNANT NEOPLASM PROGRESSION : Alimta Side Effects Report #5683092-1
ALIMTA problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 17, 2008. Female patient, 75 years of age, was diagnosed with non-small cell lung cancer, vitamin supplementation and was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, oral discomfort, respiratory failure, . ALIMTA dosage: 500 MG/M2, OTHER. During the same period patient was treated with VITAMIN B, FOLIC ACID, CORTICOSTEROID NOS. Patient died on 01/04/2008.
MALIGNANT NEOPLASM PROGRESSION : Erbitux Side Effects Report #5684893-6
Consumer or non-health professional from UNITED STATES reported ERBITUX problem on Nov 19, 2007. Female patient, 33 years of age, was diagnosed with neoplasm malignant and was treated with ERBITUX. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, . ERBITUX dosage: unknown. During the same period patient was treated with PROCRIT, CISPLATIN. Patient recovered.
MALIGNANT NEOPLASM PROGRESSION : Taxol Side Effects Report #5688538-0
TAXOL problem was reported by a Health Professional from JAPAN on Mar 28, 2008. Female patient, 58 years of age, was diagnosed with ovarian cancer and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, myelodysplastic syndrome, . TAXOL dosage: unknown. During the same period patient was treated with PARAPLATIN. Patient died.
MALIGNANT NEOPLASM PROGRESSION : Taxol Side Effects Report #5688544-6
Health Professional from JAPAN reported TAXOL problem on Mar 28, 2008. Female patient, 70 years of age, was diagnosed with ovarian cancer and was treated with TAXOL. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, myelodysplastic syndrome, . TAXOL dosage: unknown. During the same period patient was treated with PARAPLATIN. Patient died.
MALIGNANT NEOPLASM PROGRESSION : Revlimid Side Effects Report #5689360-1
REVLIMID problem was reported by a Physician from UNITED STATES on Mar 24, 2008. Male patient, 83 years of age, weighting 135.0 lb, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, multiple myeloma, . REVLIMID dosage: 25 MG, ORAL. During the same period patient was treated with KEFLEX, DECADRON, LASIX, MIRALAX, TOPROL, POTASSIUM, ALTACE, SENOKOT. Patient died on 12/06/2007.
MALIGNANT NEOPLASM PROGRESSION : Revlimid Side Effects Report #5691464-4
Physician from UNITED STATES reported REVLIMID problem on Mar 26, 2008. Female patient, 79 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, multiple myeloma, . REVLIMID dosage: unknown. Patient was hospitalized. Patient died on 02/07/2008.
MALIGNANT NEOPLASM PROGRESSION : Erlotinib Side Effects Report #5691960-X
ERLOTINIB problem was reported by a Physician from BRAZIL on Feb 21, 2008. Female patient, 40 years of age, was diagnosed with non-small cell lung cancer and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, sepsis, . ERLOTINIB dosage: 150 MG QD ORAL. Patient died on 08/13/2005.
MALIGNANT NEOPLASM PROGRESSION : Gleevec Side Effects Report #5610719-2
Consumer or non-health professional from UNITED STATES reported GLEEVEC problem on Jan 28, 2008. Male patient, 80 years of age, was diagnosed with gastric cancer and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, pneumonia aspiration, surgery, . GLEEVEC dosage: 400 MG, QD. Patient died on 12/06/2007.
MALIGNANT NEOPLASM PROGRESSION : Neupogen Side Effects Report #5613723-3
NEUPOGEN problem was reported by a Physician from UNITED STATES on Jan 22, 2008. Female patient, weighting 148.2 lb, was treated with NEUPOGEN. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, . NEUPOGEN dosage: unknown. During the same period patient was treated with CARBOPLATIN, TAXOL. Patient died on 03/26/2007.
MALIGNANT NEOPLASM PROGRESSION : Revlimid Side Effects Report #5615009-X
Health Professional from UNITED STATES reported REVLIMID problem on Jan 28, 2008. Male patient, 82 years of age, was diagnosed with multiple myeloma, neoplasm and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, multiple myeloma, platelet count decreased, . REVLIMID dosage: 15 MG, 1 IN 1 D, ORAL, 10 MG, 1 IN 1 D, ORAL. Patient died on 01/15/2008.
MALIGNANT NEOPLASM PROGRESSION : Revlimid Side Effects Report #5618801-0
REVLIMID problem was reported by a Physician from UNITED STATES on Jan 29, 2008. Male patient, 62 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, multiple myeloma, paralysis, . REVLIMID dosage: 25 MG, 1 IN 1 D, ORAL. During the same period patient was treated with DEXAMETHASONE, ZOMETA. Patient was hospitalized. Patient died on 11/23/2007.
MALIGNANT NEOPLASM PROGRESSION : Revlimid Side Effects Report #5618871-X
Physician from UNITED STATES reported REVLIMID problem on Jan 30, 2008. Female patient, 62 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, multiple myeloma, . REVLIMID dosage: 10 - 15MG, DAILY X21 DAYS EVERY 28 DAYS, ORAL. Patient died.
MALIGNANT NEOPLASM PROGRESSION : Ixempra Side Effects Report #5621890-0
IXEMPRA problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 14, 2008. Female patient, 57 years of age, was diagnosed with breast cancer metastatic and was treated with IXEMPRA. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, . IXEMPRA dosage: unknown. During the same period patient was treated with XELODA, OXYCODONE, RESTORIL, SENOKOT. Patient died on 11/10/2007.
MALIGNANT NEOPLASM PROGRESSION : Revlimid Side Effects Report #5624723-1
Physician from UNITED STATES reported REVLIMID problem on Feb 04, 2008. Female patient, 76 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, multiple myeloma, . REVLIMID dosage: 25 MG, 1 IN 1 D, ORAL. Patient died on 01/05/2008.
MALIGNANT NEOPLASM PROGRESSION : Velcade Side Effects Report #5625233-8
VELCADE problem was reported by a Physician from JAPAN on Jan 30, 2008. Female patient, 70 years of age, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, multiple myeloma, . VELCADE dosage: 1.30 MG/M2, INTRAVENOUS. Patient died on 01/10/2008.
MALIGNANT NEOPLASM PROGRESSION : Thalomid Side Effects Report #5625326-5
Physician from UNITED STATES reported THALOMID problem on Feb 04, 2008. Male patient, 80 years of age, was diagnosed with prostate cancer and was treated with THALOMID. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, metastatic malignant melanoma, prostate cancer, . THALOMID dosage: 50 MG,1 IN 1 D,ORAL. Patient died on 11/05/2007.
MALIGNANT NEOPLASM PROGRESSION : Gemzar Side Effects Report #5626288-7
GEMZAR problem was reported by a Physician from UNITED STATES on Feb 04, 2008. Female patient, 62 years of age, weighting 202.0 lb, was diagnosed with ovarian cancer recurrent and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, superior vena caval occlusion, . GEMZAR dosage: 1000 MG/M2, OTHER. During the same period patient was treated with CARBOPLATIN. Patient was hospitalized. Patient recovered.
MALIGNANT NEOPLASM PROGRESSION : Revlimid Side Effects Report #5631332-7
Physician from UNITED STATES reported REVLIMID problem on Feb 05, 2008. Male patient, 69 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, multiple myeloma, . REVLIMID dosage: 10 MG, 1 IN 1 D, ORAL; 15 MG, 1 IN 1 D, ORAL. During the same period patient was treated with VELCADE. Patient died on 08/30/2007.
MALIGNANT NEOPLASM PROGRESSION : Dilaudid Side Effects Report #5632283-4
DILAUDID problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 12, 2008. Male patient, 55 years of age, weighting 149.9 lb, was diagnosed with cancer pain, hypothyroidism and was treated with DILAUDID. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, . DILAUDID dosage: 50 MG, Q1H. During the same period patient was treated with SYNTHROID, RITALIN. Patient died on 10/26/2007.
MALIGNANT NEOPLASM PROGRESSION : Cetuximab Side Effects Report #5632515-2
Health Professional from GERMANY reported CETUXIMAB problem on Feb 15, 2008. Female patient, 68 years of age, was diagnosed with non-small cell lung cancer and was treated with CETUXIMAB. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, pulmonary embolism, . CETUXIMAB dosage: STRENGTH 2MG/ML. MOST RECENT INFUSION 21APR06. During the same period patient was treated with CISPLATIN, VINORELBINE. Patient recovered.
MALIGNANT NEOPLASM PROGRESSION : Campath Side Effects Report #5635548-5
CAMPATH problem was reported by a Physician from AUSTRIA on Feb 18, 2008. Male patient, 70 years of age, was diagnosed with chronic lymphocytic leukaemia, multiple myeloma and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, multiple myeloma, paraproteinaemia, pneumonia, . CAMPATH dosage: unknown. During the same period patient was treated with BENDAMUSTINE. Patient died on 09/30/2006.
MALIGNANT NEOPLASM PROGRESSION : Velcade Side Effects Report #5635816-7
Physician from UNITED KINGDOM reported VELCADE problem on Feb 14, 2008. Female patient was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, multiple myeloma, . VELCADE dosage: unknown. Patient died on 01/31/2008.
MALIGNANT NEOPLASM PROGRESSION : Gemcitabine Side Effects Report #5636497-9
GEMCITABINE problem was reported by a Physician from JAPAN on Feb 14, 2008. Male patient, weighting 138.9 lb, was diagnosed with lung adenocarcinoma stage ii, radiation pneumonitis and was treated with GEMCITABINE. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, myelodysplastic syndrome, radiation pneumonitis, . GEMCITABINE dosage: 1000 MG/M2, OTHER. During the same period patient was treated with PREDONINE. Patient recovered.
MALIGNANT NEOPLASM PROGRESSION : Revlimid Side Effects Report #5637170-3
Physician from UNITED STATES reported REVLIMID problem on Feb 15, 2008. Male patient, 56 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, multiple myeloma, . REVLIMID dosage: 25 MG, DAILY 3 WEEKS ON 1 WEEK OFF, ORAL. Patient died on 10/26/2007.
MALIGNANT NEOPLASM PROGRESSION : Revlimid Side Effects Report #5637183-1
REVLIMID problem was reported by a Physician from UNITED STATES on Feb 15, 2008. Male patient, 80 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, myelodysplastic syndrome, . REVLIMID dosage: 10 MG, QD, ORAL. Patient died on 05/31/2007.
MALIGNANT NEOPLASM PROGRESSION : Revlimid Side Effects Report #5637393-3
Physician from UNITED STATES reported REVLIMID problem on Feb 12, 2008. Female patient, 83 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, multiple myeloma, . REVLIMID dosage: 15 MG, QD X 21 AYS, ORAL. Patient died on 12/02/2007.
MALIGNANT NEOPLASM PROGRESSION : Revlimid Side Effects Report #5637765-7
REVLIMID problem was reported by a Health Professional from UNITED STATES on Feb 12, 2008. Male patient, 67 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, multiple myeloma, pneumonia, . REVLIMID dosage: 15 MG, 1 IN 1 D, ORAL. Patient died on 01/24/2008.
MALIGNANT NEOPLASM PROGRESSION : Cisplatin Side Effects Report #5638227-3
Consumer or non-health professional from UNITED STATES reported CISPLATIN problem on Feb 25, 2008. Male patient, 64 years of age, was diagnosed with gastric cancer, nausea, hypertension and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, neutropenia, thrombocytopenia, vomiting, . CISPLATIN dosage: unknown. During the same period patient was treated with FLUOROURACIL, METOCLOPRAMIDE, CAPTOPRIL. Patient died on 09/18/2006.
MALIGNANT NEOPLASM PROGRESSION : Revlimid Side Effects Report #5639450-4
REVLIMID problem was reported by a Physician from UNITED STATES on Feb 15, 2008. Male patient, 65 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, multiple myeloma, . REVLIMID dosage: 25 MG, 1 IN 1 D, ORAL. Patient died on 11/05/2007.
MALIGNANT NEOPLASM PROGRESSION : Zevalin Side Effects Report #5642201-0
Physician from UNITED STATES reported ZEVALIN problem on Feb 14, 2008. Male patient was diagnosed with mantle cell lymphoma and was treated with ZEVALIN. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, mantle cell lymphoma, . ZEVALIN dosage: unknown. During the same period patient was treated with RITUXAN. Patient was hospitalized. Patient recovered.
MALIGNANT NEOPLASM PROGRESSION : Revlimid Side Effects Report #5643872-5
REVLIMID problem was reported by a Physician from UNITED STATES on Feb 20, 2008. Male patient, 62 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, multiple myeloma, . REVLIMID dosage: 10 MG, 1 IN 1 D, ORAL. Patient died on 08/01/2007.
MALIGNANT NEOPLASM PROGRESSION : Revlimid Side Effects Report #5644140-8
Physician from UNITED STATES reported REVLIMID problem on Feb 21, 2008. Male patient, 67 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, multiple myeloma, . REVLIMID dosage: 10 MG, 1 IN 1 D, ORAL. Patient died on 09/11/2007.